EdenTree Asset Management’s Merck MRK Stock Holding History

EdenTree Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Sell	8,340 -45,000	-84%	-$5.27M	0.33%	57
2026 Q1	$6.42M	Sell	53,340 -41,000	-43%	-$4.73M	1.93%	21
2025 Q4	$9.93M	Sell	94,340 -83,875	-47%	-$7.87M	3.04%	8
2025 Q3	$15M	Buy	178,215 +57,350	+47%	+$4.72M	3.6%	6
2025 Q2	$9.56M	Buy	120,865 +15,000	+14%	+$1.19M	2.65%	14
2025 Q1	$9.5M	Buy	105,865 +26,225	+33%	+$2.45M	3.19%	7
2024 Q4	$7.92M	Hold	79,640	–	–	2.3%	19
2024 Q3	$9.04M	Buy	79,640 +73,840	+1,273%	+$8.77M	2.62%	14
2024 Q2	$718K	Hold	5,800	–	–	0.23%	61
2024 Q1	$765K	Sell	5,800 -10,200	-64%	-$1.26M	0.24%	62
2023 Q4	$1.74M	Buy	16,000 +500	+3%	+$51.9K	0.54%	35
2023 Q3	$1.6M	Sell	15,500 -10,000	-39%	-$1.08M	0.63%	35
2023 Q2	$2.94M	Buy	+25,500	New	+$2.9M	1.01%	30

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EdenTree Asset Management's MRK Position: Q2 2026 in Review

EdenTree Asset Management reduced its Merck (MRK) stake by 84% in Q2 2026, selling an estimated $5.27M and leaving 8,340 shares worth $1.07M. The position accounts for 0.33% of the portfolio, ranked #57.

EdenTree Asset Management first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. The position peaked at $15M in Q3 2025. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

EdenTree Asset Management held 8,340 shares of Merck worth $1.07M as of Q2 2026.
EdenTree Asset Management sold 45,000 Merck shares in Q2 2026, an estimated $5.27M.
Merck made up 0.33% of EdenTree Asset Management's portfolio in Q2 2026, its #57 holding.
EdenTree Asset Management first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
EdenTree Asset Management's Merck position peaked at $15M in Q3 2025.
3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on EdenTree Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.